Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 3Terminated 2

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Carcinoma, Non-Small-Cell Lung 5Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Rhabdoid Tumor 1Rectal Neoplasms 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chordoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Advanced Solid Malignancies 1Advanced Liver Cancers 1

Interventions

pembrolizumab 127Carboplatin 125Pemetrexed 105Cisplatin 79Paclitaxel 58osimertinib 55Nivolumab 52Docetaxel 52durvalumab 48Specimen Handling 40Magnetic Resonance Spectroscopy 36Gemcitabine 35Radiosurgery 29atezolizumab 27Cetuximab 26130-nm albumin-bound paclitaxel 26Radiotherapy 22Ipilimumab 21Drug Therapy 21cemiplimab 20Bevacizumab 20amivantamab 18Taxes 16Ramucirumab 13tislelizumab 12alectinib 12Biopsy 12lazertinib 11Radiation 11Oxaliplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Tiragolumab × 90 days × Clear all
NCT04513925 2026-06-03

SKYSCRAPER-03

Hoffmann-La Roche

Phase 3 Completed
829 enrolled 40 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04619797 2026-06-03

SKYSCRAPER-06

Hoffmann-La Roche

Phase 2/3 Completed
542 enrolled 28 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03337698 2026-05-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Terminated
314 enrolled 31 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03563716 2026-05-04

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Genentech, Inc.

Phase 2 Completed
135 enrolled 19 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04832854 2026-03-11

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 2 Terminated
50 enrolled 18 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡